BELINDA HUNT: Open Payments
NPI 1114659471 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 20 payments from 8 companies in 2025. Trend: 2023 $177 · 2024 $537 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 6 | $126 |
| GlaxoSmithKline, LLC. | 6 | $106 |
| Grifols USA, LLC | 2 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: NEFFY, NUCALA, Prolastin-C Liquid, DUPIXENT, TRELEGY ELLIPTA, Rhapsido, EOHILIA, INSPIRE.
Industry payments across NC — which companies pay providers there.
